Illumine Investment Management, LLC Neurocrine Biosciences Inc Transaction History
Illumine Investment Management, LLC
- $122 Billion
- Q1 2025
A detailed history of Illumine Investment Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Illumine Investment Management, LLC holds 9,641 shares of NBIX stock, worth $1.16 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
9,641
Previous 9,502
1.46%
Holding current value
$1.16 Million
Previous $1.3 Billion
17.79%
% of portfolio
0.87%
Previous 1.07%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
651Shares Held
96.5MCall Options Held
702KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$666 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$585 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$321 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...